Literature DB >> 24385706

Nutritional assessment with different tools in leukemia patients after hematopoietic stem cell transplantation.

Boshi Wang1, Xia Yan2, Jingjing Cai1, Yu Wang1, Peng Liu1.   

Abstract

OBJECTIVE: Correct nutritional assessment is essential for leukemia patients after hematopoietic stem cell transplantation (HSCT). This study aimed to investigate the best nutritional assessment method for leukemia patients after HSCT, and find the possible nutritional risk of the patients during the transplantation process in order to intervene in the patients with nutritional risks and undernourished patients timely, so that the entire transplantation process could be successfully completed.
METHODS: A prospective study was performed in 108 leukemia patients after HSCT, and different nutritional assessment methods, including nutritional risk screening 2002 (NRS2002), mini nutritional assessment (MNA), subjective globe assessment (SGA) and malnutritional universal screening tools (MUST), were used. The associations between nutritional status of these patients and nutritional assessment methods were analyzed.
RESULTS: A total of 108 patients completed SGA, and 99 patients completed NRS2002, MNA and MUST. During the treatment process, 85.2% of the patients lost weight, wherein, 50% lost weight greater than 5%, and 42.6% had significantly reduced food intake. For nutritional risk assessment, the positive rates of NRS2002, MNA and MUST were 100%, 74.7% and 63.6%, respectively. There was a significant difference (P<0.05) among the positive rates of NRS2002, MNA and MUST. In undernutrition assessment, the positive rate of SGA (83.3%) was significantly higher than that of MNA (17.2%) (P<0.05), and the incidence rate of nutritional risk among leukemia patients ≤30 years old was greater than that of patients >30 years old (P<0.05).
CONCLUSIONS: Patients with leukemia were in poor nutritional status during and after HSCT. The leukemia patients ≤30 years old had a greater incidence rate of nutritional risk. As nutritional risk screening tool, the specificity of NRS2002 is not high, but it can be used for evaluating nutritional deficiencies. MNA is a good nutritional risk screening tool, but not an adequate tool for nutritional assessment. If assessment of undernutrition is necessary, the combination of all these screening tools and clinical laboratory indicators should be applied to improve accuracy.

Entities:  

Keywords:  Nutritional screening; hematopoietic stem cell transplantation (HSCT); leukemia; malnutritional universal screening tools (MUST); mini nutritional assessment (MNA); nutritional risk screening 2002 (NRS2002); subjective globe assessment (SGA)

Year:  2013        PMID: 24385706      PMCID: PMC3872547          DOI: 10.3978/j.issn.1000-9604.2013.12.09

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  17 in total

1.  Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: interrelations and associations with prognosis.

Authors:  Ioannis Gioulbasanis; Panagiotis Georgoulias; Panagiotis J Vlachostergios; Vickie Baracos; Sunita Ghosh; Zoe Giannousi; Christos N Papandreou; Dimitris Mavroudis; Vassilis Georgoulias
Journal:  Lung Cancer       Date:  2011-05-31       Impact factor: 5.705

2.  ESPEN guidelines for nutrition screening 2002.

Authors:  J Kondrup; S P Allison; M Elia; B Vellas; M Plauth
Journal:  Clin Nutr       Date:  2003-08       Impact factor: 7.324

3.  Importance of parenteral nutrition in patients undergoing hemopoietic stem cell transplantation procedures in the autologous system.

Authors:  A Skop; Emilia Kolarzyk; A B Skotnicki
Journal:  JPEN J Parenter Enteral Nutr       Date:  2005 Jul-Aug       Impact factor: 4.016

Review 4.  Nutritional recommendations in hematopoietic stem cell transplantation.

Authors:  Monica Martin-Salces; Raquel de Paz; Miguel A Canales; Alfonso Mesejo; Fernando Hernandez-Navarro
Journal:  Nutrition       Date:  2008-05-12       Impact factor: 4.008

5.  NRS2002 assesses nutritional status of leukemia patients undergoing hematopoietic stem cell transplantation.

Authors:  Peng Liu; Zhao-Feng Zhang; Jing-Jing Cai; Bo-Shi Wang; Xia Yan
Journal:  Chin J Cancer Res       Date:  2012-12       Impact factor: 5.087

6.  Beyond malnutrition screening: appropriate methods to guide nutrition care for aged care residents.

Authors:  Elisabeth A Isenring; Merrilyn Banks; Maree Ferguson; Judith D Bauer
Journal:  J Acad Nutr Diet       Date:  2012-03-01       Impact factor: 4.910

7.  Baseline nutritional evaluation in metastatic lung cancer patients: Mini Nutritional Assessment versus weight loss history.

Authors:  I Gioulbasanis; V E Baracos; Z Giannousi; A Xyrafas; L Martin; V Georgoulias; D Mavroudis
Journal:  Ann Oncol       Date:  2010-10-11       Impact factor: 32.976

Review 8.  The role of nutrition and effects on the cytokine milieu in allogeneic hematopoietic stem cell transplantation.

Authors:  Lauren Zatarain; Bipin N Savani
Journal:  Cell Immunol       Date:  2012-05-17       Impact factor: 4.868

9.  [The Mini Nutritional Assessment of the elderly in the practice of a hospital geriatrics service: inception, validation and operational characteristics].

Authors:  Magdalena Cuyac Lantigua; Sergio Santana Porbén
Journal:  Arch Latinoam Nutr       Date:  2007-09

10.  Validation of screening tools to assess appetite among geriatric patients.

Authors:  R Hanisah; S Suzana; F S Lee
Journal:  J Nutr Health Aging       Date:  2012-07       Impact factor: 4.075

View more
  7 in total

1.  Comprehensive evaluation of nutritional status before and after hematopoietic stem cell transplantation in 170 patients with hematological diseases.

Authors:  Peng Liu; Boshi Wang; Xia Yan; Jingjing Cai; Yu Wang
Journal:  Chin J Cancer Res       Date:  2016-12       Impact factor: 5.087

2.  Nutritional status of allogeneic hematopoietic stem cell transplantation recipients: influencing risk factors and impact on survival.

Authors:  Amro Mohamed Sedky El-Ghammaz; Rima Ben Matoug; Maha Elzimaity; Nevine Mostafa
Journal:  Support Care Cancer       Date:  2017-04-24       Impact factor: 3.603

3.  Low serum albumin levels prior to pediatric allogeneic HCT are associated with increased need for critical care interventions and increased 6-month mortality.

Authors:  Alicia M Teagarden; Jodi L Skiles; Andrew L Beardsley; Michael J Hobson; Elizabeth A S Moser; Jamie L Renbarger; Courtney M Rowan
Journal:  Pediatr Transplant       Date:  2017-07-02

4.  Comparison of two nutrition assessment tools in surgical elderly inpatients in Northern China.

Authors:  JunDe Zhou; Miao Wang; HaiKuan Wang; Qiang Chi
Journal:  Nutr J       Date:  2015-07-14       Impact factor: 3.271

5.  A Systematic Review of the Literature and Perspectives on the Role of Biomarkers in the Management of Malnutrition After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Enrico Morello; Milena Giovanna Guarinoni; Francesco Arena; Marco Andreoli; Simona Bernardi; Michele Malagola; Alessandro Turra; Nicola Polverelli; Domenico Russo
Journal:  Front Immunol       Date:  2021-01-06       Impact factor: 7.561

6.  Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2).

Authors:  Enrico Morello; Francesco Arena; Michele Malagola; Mirko Farina; Nicola Polverelli; Elsa Cavagna; Federica Colnaghi; Lorenzo Donna; Tatiana Zollner; Eugenia Accorsi Buttini; Marco Andreoli; Chiara Ricci; Alessandro Leoni; Emanuela Samarani; Alice Bertulli; Daria Leali; Simona Bernardi; Domenico Russo
Journal:  Nutrients       Date:  2022-08-31       Impact factor: 6.706

7.  Nutritional status and hyperglycemia in the peritransplant period: a review of associations with parenteral nutrition and clinical outcomes.

Authors:  Marina Verdi Schumacher; Gustavo Adolpho Moreira Faulhaber
Journal:  Rev Bras Hematol Hemoter       Date:  2017-02-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.